Insight Molecular Diagnostics Inc.
IMDX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $260 | $518 | $2,138 | $1,486 |
| % Growth | -49.8% | -75.8% | 43.9% | – |
| Cost of Goods Sold | $121 | $168 | $813 | $891 |
| Gross Profit | $139 | $350 | $1,325 | $595 |
| % Margin | 53.5% | 67.6% | 62% | 40% |
| R&D Expenses | $3,878 | $3,281 | $2,924 | $2,257 |
| G&A Expenses | $2,545 | $2,647 | $3,115 | $3,160 |
| SG&A Expenses | $3,931 | $4,107 | $4,321 | $3,398 |
| Sales & Mktg Exp. | $1,386 | $1,460 | $1,206 | $238 |
| Other Operating Expenses | $3,378 | $2,804 | $879 | $28,567 |
| Operating Expenses | $11,187 | $10,192 | $8,124 | $34,222 |
| Operating Income | -$11,048 | -$9,842 | -$6,799 | -$33,627 |
| % Margin | -4,249.2% | -1,900% | -318% | -2,262.9% |
| Other Income/Exp. Net | $194 | $100 | $128 | $116 |
| Pre-Tax Income | -$10,854 | -$9,742 | -$6,671 | -$33,511 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$10,854 | -$9,742 | -$6,671 | -$33,511 |
| % Margin | -4,174.6% | -1,880.7% | -312% | -2,255.1% |
| EPS | -0.34 | -0.304 | -0.26 | -1.928 |
| % Growth | -11.8% | -17.2% | 86.5% | – |
| EPS Diluted | -0.34 | -0.304 | -0.26 | -1.928 |
| Weighted Avg Shares Out | 32,033 | 32,023 | 25,694 | 17,382 |
| Weighted Avg Shares Out Dil | 32,033 | 32,023 | 25,694 | 17,382 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $29 | $25 | $29 | $30 |
| Depreciation & Amortization | $584 | $559 | $491 | $563 |
| EBITDA | -$10,241 | -$9,158 | -$6,151 | -$32,918 |
| % Margin | -3,938.8% | -1,768% | -287.7% | -2,215.2% |